AngioDynamics (ANGO) Tops Q3 EPS by 2c ; Offers Guidance
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $12.47 +0.65%
EPS Growth %: -200.0%
Financial Fact:
Research and development: 6.71M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: -200.0%
Financial Fact:
Research and development: 6.71M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
AngioDynamics (NASDAQ: ANGO) reported Q3 EPS of ($0.07), $0.02 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $78.42 million versus the consensus estimate of $76.71 million.
GUIDANCE:
AngioDynamics sees FY2026 EPS of ($0.30)-($0.23), versus the consensus of ($0.29). AngioDynamics sees FY2026 revenue of $313.5-315.5 million, versus the consensus of $312.9 million.
For earnings history and earnings-related data on AngioDynamics (ANGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
- Doncasters Group guiding IPO pricing at top of range - Bloomberg
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
